Company record
ANI Pharmaceuticals, Inc.
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about ANI Pharmaceuticals, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 1 | Class III | ANI Pharmaceuticals, Inc. Drug |
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10 Presence of foreign substance |
| May 27 | Class II | ANI Pharmaceuticals, Inc. Drug |
Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20 Defective Container; packets were found to be either empty or partially full. |